Company Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.
It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.
Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Country | United States |
Founded | 1986 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 524 |
CEO | Paul Josephs |
Contact Details
Address: 3515 Lyman Boulevard Chaska, Minnesota 55318 United States | |
Phone | (952) 368-4300 |
Website | lifecore.com |
Stock Details
Ticker Symbol | LFCR |
Exchange | NASDAQ |
Fiscal Year | June - May |
Reporting Currency | USD |
CIK Code | 0001005286 |
ISIN Number | US5147661046 |
Employer ID | 94-3025618 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Paul Josephs | President, Chief Executive Officer and Director |
James G. Hall | Advisor |
Ryan D. Lake CPA | Chief Financial Officer and Secretary |
Aaron Perlitsh | Director of Internal Audit and Chief Compliance Officer |
Darren M. Hieber | Senior Vice President of Corporate Development and Partnerships |
Brikkelle Thompson | Senior Vice President of Human Resources |
Jackie Q. Klecker | Executive Vice President, Quality and Development Services and GM |
Matt Augustson | Senior Vice President of Information Technology |
Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. |
Parker K. Javid | Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 26, 2024 | 8-K | Current Report |
Nov 21, 2024 | 8-K | Current Report |
Nov 20, 2024 | 144 | Filing |
Nov 12, 2024 | 144 | Filing |
Nov 8, 2024 | 8-K | Current Report |
Oct 31, 2024 | 144 | Filing |
Oct 23, 2024 | 424B3 | Prospectus |
Oct 22, 2024 | EFFECT | Notice of Effectiveness |
Oct 18, 2024 | UPLOAD | Filing |
Oct 15, 2024 | EFFECT | Notice of Effectiveness |